|
|
Covidien plc - Medical Equipment - Deals and Alliances Profile |
| Published Date : 17 February 2010 |
|
|
|
Pages : 93 |
|
| |
|
|
|
|
|
|
|
Covidien plc - Medical Equipment - Deals and Alliances Profile
Summary
Covidien plc - Medical Equipment - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals.
Covidien plc (Covidien), formerly known as Covidien Ltd., is a leading global healthcare company. It is principally engaged in the development, manufacture and marketing of medical devices and supplies, diagnostic imaging systems, pharmaceuticals, and other healthcare products for use in the operating room and other hospital settings, long-term care, physician’s clinics, and at the home. The company supplies its products worldwide through its wholly owned subsidiaries. Covidien is headquartered in Co. Dublin, Ireland
And More inside the report…
Recent Developments
Dec 04, 2009: eMDR Rule Could Hurt Device Companies
Nov 30, 2009: Caire Acquires Oxygen Therapy Business Of Covidien
Nov 20, 2009: FDA Sets New Action Date To Review NDA For Exalgo
Scope
- Provides key company information for business intelligence needs
- Gives information on the company’s major recent financial deals including mergers & acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick “one-stop-shop” to understand the company.
- Support sales activities by understanding your customers’ businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors’ business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
Company Mentioned
The following companies are the major competitors of Covidien plc:
Bracco S.p.A.
Watson Pharmaceuticals, Inc.
Mylan Inc.
Teva Pharmaceutical Industries Limited
Lantheus Medical Imaging, Inc.
Schering AG
CareFusion Corporation
Medline Industries, Inc.
3M Company
C. R. Bard, Inc.
Johnson & Johnson
GE Healthcare
CONMED Corporation
Cardinal Health, Inc.
Becton, Dickinson and Company |
|
|
|
Table of Contents : |
2
List of Tables 5
List of Figures 6
Covidien plc, Medical Equipment, Deals By Year, 2004 to YTD 2010 7
Covidien plc, Medical Equipment Deals By Type, 2004 to YTD 2010 8
Covidien plc, Medical Equipment, Deals By Region, 2004 to YTD 2010 9
Covidien plc, Medical Equipment, Deals By Market, 2004 to YTD 2010 10
Covidien plc, Medical Equipment, Deals Summary, 2004 to YTD 2010 11
Covidien plc, Medical Equipment, Deal Details 13
Asset Purchase 13
Covidien Acquires Injection Devices From Pinyons Medical Technology 13
U.S. Surgical Acquires Absorbatack From Sorbx 14
Venture Financing 15
Power Medical Interventions Secures $14.5 Million In Series C Round Of Financing 15
Power Medical Interventions Secures $35 Million In Series B Round Of Financing 16
Partnerships 17
Power Medical Interventions Enters Into An Agreement With Intuitive Surgical 17
AngioDynamics Signs An Agreement With VNUS Medical Technologies 18
Covidien Signs An Agreement With NewSouth Innovations 19
Covidien Enters Into An Agreement With Philips Healthcare 20
Covidien Enters Into An Agreement With Drager Medical 21
Covidien Enters Into An Agreement With PETNET Solutions 22
VNUS Medical Technologies Signs An Agreement With Medtronic 23
Mallinckrodt Expands Co-Marketing Agreement Wtih Palatin Technologies 24
Echo Therapeutics Enters Into Distribution Agreement With VNUS Medical Technologies 25
SonoSite Enters Into Distribution Agreement With Nippon Sherwood 26
Equity Offering 27
Power Medical Interventions Completes Initial Public Offering Of $42.35 Million 27
VNUS Medical Technologies Completes Initial Public Offering Of $60 Million 28
Divestiture - Assets 29
Covidien Completes Sale Of Oxygen Therapy Products To Chart Industries 29
Covidien Sells Sleep Diagnostics Products To Embla Systems 30
Covidien Sells Its European Incontinence Business 31
Integra LifeSciences Holdings Acquires Assets Of Radionics Division From Covidien 32
LeMaitre Vascular Acquires AnastoClip Vessel Closure System From Tyco Healthcare 33
Debt Offering 34
Covidien Completes Private Placement Of 5.15% Senior Notes For $250 Million 34
Covidien Completes Private Placement Of 5.45% Senior Notes For $500 Million 35
Covidien Completes Private Placement Of 6% Senior Note For $1,150 Million 36
Covidien Completes Private Placement Of 6.55% Senior Notes For $850 Million 37
Acquisition 38
Covidien Completes Acquisition Of Aspect Medical Systems 38
Covidien Completes Acquisition Of Power Medical Interventions 39
Covidien Acquires VNUS Medical Technologies 40
Covidien Completes Acquisition Of Bacchus Vascular 42
Covidien Acquires CardioDigital 43
Covidien Acquires Tissue Science Laboratories 44
Covidien Acquires Scandius Biomedical From KBL Healthcare, IVY Capital Partners, Tri-Atisan And Commerce Health Capital 45
Tyco Healthcare Acquires Airox 46
U.S. Surgical Acquires Polysuture 47
Tyco Healthcare Acquires 90% Interest In Floreane Medical Implants 48
U.S. Surgical Acquires Confluent Surgical 49
Valleylab Acquires Vivant Medical 50
Key Competitors 51
Key Employees 51
Locations And Subsidiaries 52
Head Office 52
Other Locations & Subsidiaries 52
Recent Developments 54
Strategy And Business Planning 54
Apr 26, 2009: Covidien Enters Into Indian Market, Establishes Headquarters At Gurgaon, India 54
Mar 08, 2009: Covidien Will Close New York Production Plant 54
Oct 13, 2008: Covidien Opens Extension In Dublin, Ireland 54
Sep 02, 2008: Covidien To Buy Building In Mansfield For R&D And Administrative Space 54
Aug 24, 2008: Covidien Seeks Expansion And Tax Relief To Expand In Mansfield 54
Jun 19, 2008: Covidien Announces Latest Advance In ''Unite To Treat Sleep Apnea'' Initiative 55
Oct 15, 2007: Covidien, BioSynthema Signs Agreements To Develop And Commercialize Nuclear Medicine Therapy 55
Oct 04, 2007: Covidien And NewSouth Innovations Collaborate To Develop Novel Imaging Agent 56
Financial Announcements 56
Jan 20, 2010: Covidien Reports Net Income Of $412 Million In Q1 Fiscal 2010 56
Nov 17, 2009: Covidien Reports Net Sales Of $10.67 Billion In Fiscal 2009 57
Jul 30, 2009: Covidien Posts $281 Million Net Income In Q3 Fiscal 2009 59
Apr 30, 2009: Covidien Posts $184 Million Profit In Q2 Fiscal 2009 60
Mar 17, 2009: Covidien Declares Quarterly Dividend 61
Jan 28, 2009: Covidien Declares Quarterly Dividend 61
Jan 26, 2009: Covidien Reports Q1 Fiscal 2009 Results 61
Jan 07, 2009: Covidien To Declare Q1 2009 Results 62
Dec 01, 2008: Covidien Spends $0.45 Million On Lobbying In 3Q 2008 63
Nov 17, 2008: Covidien Reports Fiscal 2008 Results 63
Oct 17, 2008: Covidien Plans To Invest $100 Million In St. Louis County Facilities 64
Oct 08, 2008: Covidien To Declare 4Q 2008 Results 66
Sep 29, 2008: Covidien Declares Quarterly Dividend 66
Sep 12, 2008: Covidien Spends $0.37 Million On Lobbying In 2Q 2008 66
Sep 10, 2008: Covidien Provides Financial Guidance For Fiscal 2009 66
Aug 05, 2008: Covidien Declares 3Q Fiscal 2008 Results 66
Jul 16, 2008: Covidien Declares Quarterly Dividend 68
May 08, 2008: Covidien Declares Quarterly Dividend 68
May 06, 2008: Covidien Declares Q2 Fiscal 2008 Results 68
Apr 09, 2008: Covidien To Declare Q2 2008 Results 70
Mar 28, 2008: Covidien Spends $760,000 Lobbying Federal Government In 2007 70
Mar 18, 2008: Covidien Declares Quarterly Dividend 70
Feb 07, 2008: Covidien Declares Q1 Fiscal 2008 Results 70
Jan 15, 2008: Covidien Declares Quarterly Dividend 72
Jan 10, 2008: Covidien To Declare Q1 Fiscal 2008 Results 72
Dec 06, 2007: Covidien Reports Q4 Fiscal 2007 Results 72
Sep 28, 2007: Covidien Declares Quarterly Dividend 73
Aug 09, 2007: Covidien Declares Q3 Fiscal 2007 Results 73
Research And Development 74
Sep 02, 2008: Covidien To Buy Building In Mansfield For R&D And Administrative Space 74
Jun 19, 2008: Covidien Announces Latest Advance In ''Unite To Treat Sleep Apnea'' Initiative 74
Oct 15, 2007: Covidien, BioSynthema Signs Agreements To Develop And Commercialize Nuclear Medicine Therapy 75
Corporate Communications 76
Sep 21, 2009: Covidien To Lay Off Around 70 Workforce At Its Norfolk Medical Supplies Plant 76
Jul 08, 2009: Covidien Lays Off 119 Workers From Its Seneca Plant 76
Sep 29, 2008: Covidien Elects New Chairman 76
Jun 30, 2008: Covidien Appoints New R&D Executives In Its Pharmaceutical And Imaging Businesses 77
Jun 30, 2008: Covidien Announces Management Appointments 78
Legal and Regulatory 78
Jan 14, 2010: Covidien Sues Ethicon Endo- Surgery Over Ultrasonic Surgical Devices 78
Jan 11, 2010: Masimo Receives Payment Following Court Of Appeals Affirmance Of Antitrust Liability Verdict Against Tyco HealthCare 79
May 04, 2009: Attorney General Cox, Treasurer Kleine Recover $24.5 Million For State Pension Fund 79
Apr 21, 2009: Covidien Files Patent Infringement Lawsuit Against Davol 80
Jan 15, 2009: Rochester Announces Settlement With Covidien To Resolve Litigation 80
Feb 21, 2008: Covidien Gests Favorable Decision In Patent Litigation Case 80
Government and Public Interest 80
Dec 04, 2009: eMDR Rule Could Hurt Device Companies 80
Product News 81
Jan 09, 2010: Covidien Plans To Complete Phase I Netherlands Trial For Parietene Composite Mesh In Second Half Of 2012 81
Nov 11, 2009: Covidien Unveils DuraSeal Spine Sealant 81
Oct 19, 2009: Covidien Launches Mallinckrodt TaperGuard And TaperGuard Evac Endotracheal Tubes 81
Oct 12, 2009: Covidien Announces Worldwide Launch Of V-Loc Absorbable Wound Closure Device 82
Sep 30, 2009: Covidien Announces FDA Approval For Mallinckrodt TaperGuard Evac Endotracheal Tube 82
Sep 11, 2009: Covidien Announces Class I Recall For Pedi-Cap End-Tidal< |
|
|
|
Published By : Global Markets Direct |
|
|
Related
Keywords:
Energy,
Insurance, Financial,
Company Profile,
Industry Profile,
Swot Analysis,
Apparel,
Consumer, Trade,
Information technology,
Food,
Healthcare,
Construction,
Retail,
Design,Oil
and Gas,
Solar,
Miscellaneous,
Business,
Pharmaceuticals,
Technology,
Defense,
Medical,
Travel,
Power,
Metal
|
|
|
|
